This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

JM-010

Bukwang Pharm. Co., Ltd.

Drug Names(s): CTP-010

Description: JM-010 is a new drug combination comprised of undisclosed compounds intended to treat dyskinesia.

Deal Structure: In November 2013, Concit Pharma has changed its corporate name to Contera Pharma.

Contera and Bukwang
In November 2014, Contera Pharma announced that Bukwang Pharmaceutical (Seoul, Korea) has acquired 100% of Contera Pharma from its current shareholders. The shareholders received an undisclosed upfront payment and are entitled to future contingent and royalty payments.


JM-010 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug